Synthesis and characterization of substituted pyrazino[2′,3′:4, 5]thieno[3,2-d]pyrimidines and related molecules

Synthesis

Volumn , Issue 6, 2011, Pages 943-953

  Fernández Mato, Antonio ^a   Peinador, Carlos ^a   Quintela, José M ^a  

^a UNIVERSITY OF A CORUÑA   (Spain)

Author keywords

antitumor agents; fused ring systems; heterocycles; ligands; ring closure

Indexed keywords

ANTI-TUMOR AGENTS; FUNCTIONALIZATIONS; FUNCTIONALIZED; FUSED-RING SYSTEMS; HETEROCYCLES; NITROGEN LIGAND; PYRAZINES; RING CLOSURE; SYNTHETIC METHODS; SYNTHETIC ROUTES; TITLE COMPOUNDS;

AROMATIC COMPOUNDS; CHELATION; CHLORINE COMPOUNDS; LIGANDS;

SYNTHESIS (CHEMICAL);

1,2,3 TRIAZINE DERIVATIVE; 2 (DIMETHYLAMINO) 4 (MORPHOLIN 4 YL)PYRAZINO[2',3':4,5]THIENO[3,2 D]PYRIMIDINE; 7 [[(DIMETHYLAMINO)ETHOXYMETHYLENE]AMINO]THIENO[2,3 B]PYRAZINE 6 CARBONITRILE; CHLOROACETONITRILE; CISPLATIN; HYDROCHLORIC ACID; PYRAZINE DERIVATIVE; PYRAZINO[2',3':4,5]THIENO[3,2 D] 1,2,3 TRIAZINE DERIVATIVE; PYRAZINO[2',3':4,5]THIENO[3,2 D]PYRIMIDINE DERIVATIVE; PYRIMIDINE DERIVATIVE; SODIUM NITRITE; THIENO[3,2 D]PYRIMIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL REACTION; CHROMATOGRAPHY; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; INFRARED SPECTROSCOPY; MASS SPECTROMETRY; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 79952452514     PISSN: 00397881     EISSN: 1437210X     Source Type: Journal    
DOI: 10.1055/s-0030-1258432     Document Type: Article

References (61)

1. Pitt R W., Parry D M., Perry B G., Groom C R., J. Med. Chem. 2009 52 2952
2. Carr R A. E., Congreve M, Murray C W., Rees D C., Drug Discovery Today 2005 10 987
3. For recent contributions, see:, Haraguchi K, Kubota Y, Tanaka H, J. Org. Chem. 2004 69 1831
4. Depecker G, Patino N, Giorgio C D., Terreux R, Cabrol-Bass D, Bailly C, Aubertin A.-M, Condom R, Org. Biomol. Chem. 2004 2 74
5. Palacios F, Alonso C, Amezua P, Rubiales G, J. Org. Chem. 2002 67 1941; and references cited therein
6. Renslo A R., Danheiser R L., J. Org. Chem. 1998 63 7840
7. Neuschütz K, Velker J, Neier R, Synthesis 1998 227
8. Ihara M, Fukumoto K, Nat. Prod. Rep. 1997 14 413
9. Taylor E C., Dowling J E., J. Org. Chem. 1997 62 1599; and pertinent references cited therein
10. Jones G, In Comprehensive Heterocyclic Chemistry II Vol. 5 Katritzky A R. Rees C W. Scriven E F. V. McKillop A Pergamon Oxford 1996
11. Oikawa T, Kanomata N, Tada M, J. Org. Chem. 1993 58 2046
12. For examples, see
13. Chambhare R V., Khadse B G., Bobde A S., Bahekar R H., Eur. J. Med. Chem. 2003 38 89
14. Sishoo C J., Shirsath V S., Rathod I S., Yande V D., Eur. J. Med. Chem. 2000 35 351
15. Varvounis G, Giannopoulos T, Adv. Heterocycl. Chem. 1996 66 193
16. Backhite E A.-G, Phosphorus, Sulfur Silicon Relat. Elem. 2003 178 929
17. Litvinov V P., Dotsenko V V., Krivokolysko S G., Russ. Chem. Bull. 2005 54 864
18. Quintela J M., González L, Devesa I, Ferrándiz M L., Alcaraz M J., Riguera R, Bioorg. Med. Chem. 2003 11 863
19. Quintela J M., Peinador C, Moreira M J., Alfonso A, Botana L M., Riguera R, Eur. J. Med. Chem. 2001 36 321
20. Quintela J M., Peinador C, Veiga C, González L, Botana L M., Alfonso A, Riguera R, Bioorg. Med. Chem. 1998 6 1911
21. Martínez-Poveda B, Muñoz-Chápuli R, Rodríguez-Nieto S, Quintela J M., Fernndez A, Medina M A., Quesada A R., Mol. Cancer Ther. 2007 6 2675
22. Rioja I, Ubeda A, Terencio M C., Guillén I, Riguera R, Quintela J M., Peinador C, González L, Alcaraz M J., Eur. J. Pharmacol. 2000 397 207
23. Quintela J M., Peinador C, González L M., Rioja I, Terencio M C., Ubeda A, Alcaraz M J., Riguera R, J. Med. Chem. 1999 42 4720
24. Quintela J M., Peinador C, González L, Iglesias R, Paramá A, Alvarez F, Sanmartín M, Riguera R, Eur. J. Med. Chem. 2003 38 265
25. Chill L, Aknin M, Kashman Y, Org. Lett. 2003 5 2433
26. Pettit G R., Tan R, Xu J, Ichihara Y, Williams M D., Boyd M R., J. Nat. Prod. 1998 61 955
27. Immamura N, Nishijima M, Takadera T, Adachi K, Sakai M, Sano H, J. Antibiot. 1997 50 8
28. Baker D C., Hand E S., Plowman J, Rampal J B., Safavy A, Haugwitz R D., Narayanan V L., Anti-Cancer Drug Des. 1987 2 297
29. For a recent review, see:, Pawar V G., De Borggraeve W H., Synthesis 2006 2799
30. For a recent example, see:, Burns C J., Wil ks A F., Bu X, WO 2005,054,230 2005; Chem. Abstr. 2005, 143, 60004o
31. Abboto A, Bradamante S, Facchetti A, Pagani G A., J. Org. Chem. 2002 67 5753
32. Wang S, Coord. Chem. Rev. 2001 215 79
33. Balzani V, Juris A, Venturi M, Campagna S, Serroni S, Chem. Rev. 1996 96 759
34. Di Bella S, Chem. Soc. Rev. 2001 30 355
35. Schubert U S., Hofmeier H, Newkome G R., Modern Terpyridine Chemistry Wiley-VCH Weinheim 2006
36. Chelucci G, Thummel R P., Chem. Rev. 2002 102 3129
37. Fache F, Schulz E, Thommasino M L., Lemaire M, Chem. Rev. 2000 100 2159
38. Garas A M. S., Vagg R S., J. Heterocycl. Chem. 2000 37 151; and references cited therein
39. Encyclopedia of Supramolecular Chemistry Atwood J L. Steed J W. Marcel Dekker New York 2004
40. Steed J W., Atwood J L., Supramolecular Chemistry John Wiley & Sons New York 2000
41. Lehn J.-M, Supramolecular Chemistry: Concepts and Prospectives VCH Weinheim 1995
42. Steel P J., Acc. Chem. Res. 2005 38 243
43. Blanco G, Fernández-Mato A, Quintela J M., Peinador C, Synthesis 2009 438
44. Blanco G, Fernández-Mato A, Quintela J M., Peinador C, Tetrahedron 2008 64 11136
45. Fernández-Mato A, Blanco G, Quintela J M., Peinador C, Tetrahedron 2008 64 3446
46. Blanco G, Quintela J M., Peinador C, Synthesis 2007 1397
47. Blanco G, Quintela J M., Peinador C, Tetrahedron 2007 63 2034
48. Blanco G, Seguí N, Quintela J M., Peinador C, Chas M, Toba R, Tetrahedron 2006 62 11124
49. Blanco G, Quintela J M., Peinador C, J. Heterocycl. Chem. 2006 43 1051
50. Johnston D B. R., US 4,442,095 1984
51. Schneller S W., Clough F W., J. Heterocycl. Chem. 1975 12 513
52. For a review see:, Janousek Z, Viehe H G., In Iminium Salts in Organic Chemistry, Advances in Organic Chemistry: Chemistry of Dichloromethyleniminium Salts (Phosgeniminium Salts) Vol. 9 Böhme H Viehe H G. John Wiley & Sons New York 1976 343
53. Peinador C, Quintela J M., Moreira M J., Tetrahedron 1997 53 8269
54. Kokel B, Menichi G, Hobar-Habart M, Tetrahedron Lett. 1984 25 1557
55. Guillot N, Viehe H G., Tinault B, DeClerq J P., Tetrahedron 1990 46 3897
56. Bemis G W., Murcko M A., J. Med. Chem. 1996 39 2887
57. Quintela J M., Peinador C, Veiga M C., Botana L M., Alfonso A, Riguera R, Eur. J. Med. Chem. 1998 33 887
58. Beck J R., Yahner J A., J. Org. Chem. 1976 41 1733
59. Hotze A C. G., Bacac M, Velders A H., Jansen B A. J., Kooijman H, Spek A L., Haasnoot J G., Reedijk J, J. Med. Chem. 2003 46 1743
60. Dimmock J R., Vashishtha S C., Quali J W., Pugazhenthi U, Zimple Z, Sudom A M., Allen T M., Kao G Y., Balzarini J, DeClercq E, J. Med. Chem. 1999 42 4012
61. Buckley R G., Elsome A M., Fricker S P., Henderson G R., Theobald B R. C., Parish R V., Howe B P., Kelland L R., J. Med. Chem. 1996 39 5208